| 2.6 |
7.9 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 1.4 |
4.1 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 1.2 |
1.2 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 1.2 |
6.1 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 1.2 |
8.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.0 |
3.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.0 |
4.1 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 1.0 |
3.0 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 1.0 |
3.0 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.9 |
2.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.9 |
2.7 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.9 |
3.5 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.9 |
5.1 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.8 |
2.5 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.8 |
2.5 |
GO:0060769 |
positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
| 0.8 |
3.3 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.8 |
7.2 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.8 |
2.4 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.8 |
1.5 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.8 |
2.3 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.7 |
2.2 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.7 |
2.9 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.7 |
2.1 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.7 |
3.5 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.7 |
11.0 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.7 |
3.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.7 |
4.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.7 |
2.0 |
GO:1905065 |
hematopoietic stem cell migration(GO:0035701) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.6 |
1.9 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.6 |
1.9 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.6 |
2.5 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.6 |
3.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.6 |
4.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.6 |
6.7 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.6 |
2.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.6 |
2.4 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.6 |
1.7 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.6 |
11.4 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.6 |
1.7 |
GO:0007403 |
glial cell fate determination(GO:0007403) pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.5 |
3.3 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.5 |
3.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.5 |
1.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.5 |
1.5 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.5 |
1.5 |
GO:0000430 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.5 |
1.5 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.5 |
1.5 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.5 |
6.4 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.5 |
1.0 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.5 |
1.9 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.5 |
1.9 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.5 |
2.8 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.5 |
1.4 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.5 |
2.3 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.5 |
1.4 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.5 |
1.4 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.4 |
1.8 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.4 |
2.7 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.4 |
3.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.4 |
1.8 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.4 |
1.3 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.4 |
2.1 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.4 |
2.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.4 |
2.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.4 |
5.2 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.4 |
1.5 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.4 |
2.9 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.4 |
2.2 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.4 |
4.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 |
1.8 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.4 |
2.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.4 |
3.3 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.4 |
2.9 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.4 |
4.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.4 |
2.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.3 |
1.0 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.3 |
1.4 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 |
2.0 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.3 |
0.7 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.3 |
3.2 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.3 |
3.8 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 |
2.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
1.2 |
GO:2000427 |
apolipoprotein A-I-mediated signaling pathway(GO:0038027) regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 |
0.6 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.3 |
1.2 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.3 |
1.8 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.3 |
1.2 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.3 |
0.6 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.3 |
2.8 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.3 |
1.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
1.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
1.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 |
1.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
0.3 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.3 |
1.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 |
2.1 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.3 |
1.3 |
GO:0046684 |
response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.3 |
0.3 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.3 |
0.5 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.2 |
1.7 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.2 |
1.9 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 |
7.3 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.2 |
1.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.2 |
0.7 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
0.7 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.2 |
4.5 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.2 |
0.9 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 |
3.9 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.2 |
3.4 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.2 |
2.2 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.2 |
3.5 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.2 |
1.3 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
0.7 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.2 |
3.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
0.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.2 |
1.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.8 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.2 |
2.5 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
2.7 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 |
0.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 |
0.6 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
0.6 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.2 |
0.9 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.2 |
0.9 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.2 |
0.7 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.2 |
0.7 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
0.5 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
1.9 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.7 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 |
2.4 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
0.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 |
1.0 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 |
2.5 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
0.2 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.2 |
1.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
3.6 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 |
9.1 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.2 |
2.4 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 |
0.8 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
1.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.6 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.2 |
1.7 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.2 |
0.3 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.2 |
0.8 |
GO:0051012 |
microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.1 |
1.3 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 |
0.4 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
1.0 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
1.0 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.4 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.1 |
0.4 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
1.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.4 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.1 |
0.7 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 |
0.8 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
3.7 |
GO:0060669 |
embryonic placenta morphogenesis(GO:0060669) |
| 0.1 |
0.5 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
3.0 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.1 |
0.5 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.1 |
0.9 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
2.5 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 |
0.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.3 |
GO:0097709 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) regulation of renin secretion into blood stream(GO:1900133) |
| 0.1 |
3.2 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
0.4 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.1 |
2.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.4 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) disruption by symbiont of host cell(GO:0044004) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) positive regulation of apoptotic process in other organism(GO:0044533) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) positive regulation by symbiont of host programmed cell death(GO:0052042) modulation by symbiont of host apoptotic process(GO:0052150) positive regulation by symbiont of host apoptotic process(GO:0052151) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 |
0.4 |
GO:0021514 |
ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.1 |
2.4 |
GO:0021799 |
cerebral cortex radially oriented cell migration(GO:0021799) |
| 0.1 |
0.8 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.4 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.1 |
1.0 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 |
0.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
1.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
1.7 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
0.5 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
1.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
1.4 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.7 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
1.8 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.7 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
1.1 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.1 |
1.8 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.5 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.3 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.7 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
1.0 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.5 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.7 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.9 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.7 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
1.7 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
1.4 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
0.4 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.4 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
1.0 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.3 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
2.1 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.5 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
7.4 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.1 |
0.4 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
1.0 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) |
| 0.1 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
1.7 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.9 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.4 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
1.2 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.1 |
0.4 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.1 |
1.7 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.1 |
1.2 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.1 |
2.6 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.1 |
3.6 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.1 |
0.7 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
2.1 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
0.4 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 |
0.8 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
1.6 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
2.7 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
1.1 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
0.3 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.1 |
1.5 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 |
0.2 |
GO:0071864 |
positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.1 |
0.5 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 |
4.8 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.1 |
2.5 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.4 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.5 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.3 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
2.9 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 |
0.2 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.8 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.2 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.1 |
2.0 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 |
0.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
1.4 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
1.9 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.1 |
0.6 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 |
1.3 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.4 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 |
0.8 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
1.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.7 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.3 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.1 |
1.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
2.6 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
3.1 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.6 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.1 |
3.9 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
0.3 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.1 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.4 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
4.3 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.1 |
0.1 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.1 |
0.5 |
GO:1900271 |
regulation of long-term synaptic potentiation(GO:1900271) |
| 0.1 |
0.5 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.2 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.2 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 |
0.7 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
1.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.6 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.6 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
2.3 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
0.8 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.1 |
1.1 |
GO:0060384 |
innervation(GO:0060384) |
| 0.1 |
0.3 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.3 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.1 |
0.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.5 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.1 |
0.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 |
0.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.3 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.4 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.0 |
0.5 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.0 |
0.4 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.8 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.0 |
0.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.7 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.2 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.0 |
0.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
3.2 |
GO:0030518 |
intracellular steroid hormone receptor signaling pathway(GO:0030518) |
| 0.0 |
0.4 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.0 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.3 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
1.0 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.1 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) N-terminal peptidyl-lysine acetylation(GO:0018076) positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.0 |
0.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.0 |
0.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.2 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.4 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.2 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.9 |
GO:0060291 |
long-term synaptic potentiation(GO:0060291) |
| 0.0 |
1.2 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.0 |
1.8 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.3 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.0 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.3 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.4 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
1.0 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.0 |
1.2 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
1.7 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.5 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.4 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.0 |
0.9 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.0 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.0 |
0.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.1 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.0 |
0.1 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.0 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.8 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.9 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.0 |
2.6 |
GO:0098742 |
cell-cell adhesion via plasma-membrane adhesion molecules(GO:0098742) |
| 0.0 |
0.3 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
1.4 |
GO:0019319 |
hexose biosynthetic process(GO:0019319) |
| 0.0 |
0.2 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.3 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.6 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.1 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.2 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.1 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) establishment of mitotic spindle localization(GO:0040001) |
| 0.0 |
0.3 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.0 |
0.3 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.6 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.4 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
0.8 |
GO:0045834 |
positive regulation of lipid metabolic process(GO:0045834) |
| 0.0 |
0.2 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.1 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.0 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.1 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
0.7 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.2 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
| 0.0 |
0.7 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.2 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.2 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.6 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 0.0 |
3.2 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.0 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.0 |
1.3 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
1.0 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
0.2 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.1 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.0 |
0.4 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.9 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 |
0.1 |
GO:0071364 |
response to epidermal growth factor(GO:0070849) cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 |
0.1 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.0 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.5 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
1.1 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
| 0.0 |
2.1 |
GO:0008154 |
actin polymerization or depolymerization(GO:0008154) |
| 0.0 |
0.3 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.4 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.2 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.3 |
GO:0097202 |
activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.0 |
0.0 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.2 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.3 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.7 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
0.4 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.2 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
0.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
1.1 |
GO:0048515 |
spermatid differentiation(GO:0048515) |
| 0.0 |
0.1 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.0 |
0.6 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.1 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.0 |
1.0 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.0 |
2.0 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.0 |
0.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
